Integer Holdings Corporation
Integer Holdings Corporation specializes in developing and manufacturing a wide array of medical devices and components, primarily for the urology, oncology, and cardiovascular markets.
Services
Integer Holdings Corporation provides a broad range of development and manufacturing solutions for the urology market. The company offers advanced catheter components and finished support catheters, catering to the specific needs of healthcare providers. Additionally, it manufactures arterial and venous introducers, ensuring comprehensive coverage of various medical needs. Upon regulatory approval, Integer Holdings Corporation also provides instructions for use (IFU) links for its products.
Products
Integer Holdings Corporation produces a diverse array of medical products, including industry-leading PTFE angiographic guidewires and advanced medical guidewire technology with custom solutions. The company manufactures high energy wet tantalum capacitors and batteries designed for medical devices, reflecting their commitment to quality and reliability. Furthermore, Integer offers a broad range of medical components and finished devices tailored for oncology treatments, underscoring their versatility in addressing different medical fields.
Medical Guidewire Technology
The company is renowned for its advanced medical guidewire technology. Integer Holdings Corporation offers custom solutions to meet specific medical needs, including industry-leading PTFE angiographic guidewires. This technology is pivotal in various medical procedures, ensuring high performance and precision. By providing tailored solutions, Integer Holdings Corporation supports healthcare providers in delivering optimal patient outcomes.
Medical Components for Oncology
Integer Holdings Corporation produces a broad range of medical components and finished devices specifically designed for oncological applications. This comprehensive approach to oncology ensures that medical practitioners have the necessary tools and devices for effective treatment. The company’s focus on oncology enhances the ability to cater to the specialized needs of oncology patients, contributing to improved care and treatment options.